Search

The article looks at nine significant issues that glaucoma patients should know about the ocular disease. Topics mentioned include a study that looked at patients diagnosed between 1981 and 2000 compared with patients diagnosed between 1965 and 1980 in the same geographic location, the best treatments for glaucoma, and blurred vision or vision loss caused by angle closure glaucoma.

The article discusses the story of glaucoma patient Robert C. Randall's successful fight to get marijuana legally from the U.S. federal government to treat his disease. Randall was diagnosed by an ophthalmologist of having glaucoma in 1972. In 1975, he was charged by the government for cultivating marijuana in his apartment in Washington, D.C. He used the research of Robert Hepler about clinical trials on marijuana and glaucoma in his defense. In November 1976, Randall received his first supplies of marijuana from the government. INSET: THE PHARMACIST'S CHALLENGE.

The article looks at some glaucoma treatment alternatives, which may expand beyond surgery, medication, and lasers. They include marijuana, ginkgo, and memantine. Also mentioned are acupuncture, meditation, perfusion pressure, and other supplements such as black currant, Mirtogenol tablets, and palmitoylethanolamide.

Cites a study which claimed that smoking marijuana is neither an effective nor a safe method of lowering IOP in glaucoma patients. Key findings of the report by researcher Keith Green; Health hazards of marijuana; Cognitive effects induced by marijuana; Movement to legalize use of marijuana for health reasons.

The article discusses the different truths and myths about medical marijuana. Topics covered include how the recreational use of marijuana in small quantities is legal in Colorado and Washington. Also mentioned are the adverse effects to using medical marijuana like respiratory and cardiovascular problems and the proper administration of medical marijuana.

The article reports on the statement released by the American Academy of Ophthalmology (AAOphth) in which it reiterated its stance on medical marijuana as an effective long-term treatment for glaucoma.